<DOC>
	<DOCNO>NCT02759562</DOCNO>
	<brief_summary>This study evaluate effect andecaliximab ( formerly GS-5745 ) pre-bronchodilator FEV1 adult cystic fibrosis ( CF ) 8 week treatment . There 2 part study . In Part 1 , andecaliximab 600 mg placebo administer 8 week . In Part 2 , andecaliximab 300 mg , 150 mg , placebo administer 8 week . Part 2 initiated completion Part 1 .</brief_summary>
	<brief_title>Effect Andecaliximab FEV1 Adults With Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>Key Confirmed diagnosis CF determine 2008 Cystic Fibrosis Foundation Consensus Report criterion Must body weight &gt; 40 kg ( 88.2 lb ) study screen Prebronchodilator FEV1 ≥ 40 % ≤ 80 % predict screen Two prebronchodilator spirometry measure screen baseline must meet follow 2 criterion : The relative difference FEV1 ( L ) , calculate absolute value [ ( first FEV1 second FEV1 ) / first FEV1 ] x 100 &lt; 12 % AND The absolute difference FEV1 &lt; 200 ml Negative Sputum Investigation/History Mycobacterium spp . Burkholderia spp . per specify protocoldefined time period Clinically stable evidence significant respiratory symptom would require administration IV antibiotic , oxygen supplementation , hospitalization within 30 day baseline . On stable CF chronic medical regimen least 30 day prior baseline expect remain stable completion study . This include limited : chronic azithromycin use , inhaled bronchodilator , inhaled corticosteroid , inhaled dornase alpha , inhale hypertonic saline , inhaled mannitol , ivacaftor , and/or ivacaftor/lumacaftor . Key Concurrent use oral antibiotic ( exclude chronic azithromycin use ) IV antibiotic within 30 day baseline . Prophylactic chronic doxycycline use prohibit study . Hospitalization respiratory event within 30 day baseline Current use systemic immunosuppressive drug include oral corticosteroid within 30 day Baseline Current requirement daily continuous oxygen supplementation requirement ( medically necessary ) 2 L/minute night ( subject would meet exclusion criterion supplemental oxygen use comfort ) History solid organ ( include lung ) hematologic transplant , currently transplant wait list Note : Other protocol define Inclusion/Exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>